Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Gastrointestinal mucositis (“mucositis”), is a form of mucosal barrier injury, occur as a severe side effect of many anticancer treatments. Unfortunately such therapy affects all rapidly dividing cells whether neoplastic or not. Since intestinal epithelial cells divide rapidly, chemotherapy can disrupt the intestinal epithelial barrier, leading to mitotic arrest in the crypts and villous blunting. Clinically the use of these drugs is often limited due to its side effects such as severe nausea and widespread gastrointestinal ulceration resulted in diarrhea as a main clinical characteristic [1]. Mucositis increases the morbidity of the patients undergoing cancer treatment, results in extended hospital stays and re- admission rates are also increased
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi